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Effects of hyperbaric oxygen on eye tracking abnormalities in males 
after mild traumatic brain injury
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MS;4 William Carne, PhD1*
1Department of Physical Medicine and Rehabilitation, Virginia Commonwealth University, Richmond, VA; 2Physical 
Medicine and Rehabilitation Program Office, Department of Veterans Affairs, Richmond, VA; 3Department of Mathe-
matics and Computer Science, University of Richmond, Richmond, VA; 4Department of Biomedical Engineering, Vir-
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Abstract—The effects of hyperbaric oxygen (HBO2) on eye 
movement abnormalities in 60 military servicemembers with at 
least one mild traumatic brain injury (mTBI) from combat 
were examined in a single-center, randomized, double-blind, 
sham-controlled, prospective study at the Naval Medicine 
Operational Training Center. During the 10 wk of the study, 
each subject was delivered a series of 40, once a day, hyper-
baric chamber compressions at a pressure of 2.0 atmospheres 
absolute (ATA). At each session, subjects breathed one of three 
preassigned oxygen fractions (10.5%, 75%, or 100%) for 1 h, 
resulting in an oxygen exposure equivalent to breathing either 
surface air, 100% oxygen at 1.5 ATA, or 100% oxygen at 2.0 
ATA, respectively. Using a standardized, validated, computer-
ized eye tracking protocol, fixation, saccades, and smooth pur-
suit eye movements were measured just prior to intervention 
and immediately postintervention. Between- and within-groups 
testing of pre- and postintervention means revealed no signifi-
cant differences on eye movement abnormalities and no signif-
icant main effect for HBO2 at either 1.5 ATA or 2.0 ATA 
equivalent compared with the sham-control. This study demon-
strated that neither 1.5 nor 2.0 ATA equivalent HBO2 had an 
effect on postconcussive eye movement abnormalities after 
mTBI when compared with a sham-control.
Key words: blast injury, blinded, concussion, eye tracking, 
hyperbaric oxygen, postconcussive syndrome, randomized, 
saccades, sham controlled, traumatic brain injury.
INTRODUCTION
As a result of the significant numbers of Veterans and 
servicemembers (SMs) who sustained mild traumatic 
brain injuries (mTBI) from the Gulf wars, the U.S. 
Department of Veterans Affairs (VA) and Department of 
Defense (DoD) established integrated systems of care [1–
2]. Through 2011, nearly 1 in 10 Veterans who served in 
Operation Enduring Freedom and Operation Iraqi Free-
dom and enrolled in the VA were diagnosed with at least 
one deployment-related mTBI [3]. Of these individuals, 
Abbreviations: ANOVA = analysis of variance, ATA = atmo-
spheres absolute, DoD = Department of Defense, HBO2 = 
hyperbaric oxygen, mTBI = mild traumatic brain injury, 
NMOTC = Naval Medicine Operational Training Center, 
PPCS = persistent postconcussive syndrome, RPQ = River-
mead Post-Concussion Questionnaire, SD = standard devia-
tion, SM = servicemember, SPEM = smooth pursuit eye 
movement, TBI = traumatic brain injury, VA = Department of 
Veterans Affairs.
*Address all correspondence to William Carne, PhD; 
Department of PM&R, Virginia Commonwealth Univer-
sity, 1223 East Marshall Street, Richmond, VA 23298; 804-
828-4231; fax: 804-828-6755. Email: lasile@aol.com
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more than 90 percent were also diagnosed with at least 
one additional condition (e.g., posttraumatic stress disor-
der or pain) that likely complicated both the clinical pre-
sentation and subsequent treatment [3–4], a finding that 
has been labeled Postdeployment Syndrome [5] and may 
help explain the higher rate of persistent postconcussive 
syndrome (PPCS) in military personnel than civilian 
individuals [3]. Moreover, the high incidence of repeated 
exposures to blast, with potential for cumulative brain 
injury, may also contribute to prolongation of recovery 
and difficulty in symptom attribution [6–7]. The persis-
tence of often disabling symptoms in a high proportion of 
returning SMs and Veterans has prompted the use of a 
significant number of alternative treatment strategies, 
including meditation, acupuncture, tai chi, continuum 
movement therapy, and hyperbaric oxygen (HBO2) [3–8].
HBO2 has been advocated for the acute treatment of 
carbon monoxide poisoning, burns, crush injuries, and air 
embolism; the chronic management of pressure ulcers, 
gangrene, radiation necrosis, brain abscess, anemia, 
osteomyelitis, and retinal artery blockage; and to improve 
the long-term effects of ischemic stroke, autism, and 
cerebral palsy [9]. However, investigations evaluating the 
effect of HBO2 on subjective measures of PPCS have not 
demonstrated clinically meaningful improvement [8,10–
12]. In contrast to this lack of efficacy in subjective mea-
sures of brain dysfunction, there are many basic science 
studies supporting the effects of HBO2 on objective find-
ings of brain recovery in animals [13]. For example, in 
brain-injured rodents, HBO2 promotes mitochondrial 
recovery and decreases apoptosis in hypoxic nerve cells, 
which is associated with cognitive recovery and a reduc-
tion in hippocampal neuronal cell loss [13–15]. The pur-
ported mechanisms of HBO2 on brain injury include 
enhanced neural stem cell activation and growth, reduced 
hypoxic-induced myelin damage, elevated cellular ATP 
(adenosine triphosphate) levels, and upregulated HIF-1 
(hypoxis-inducible factor-1) alpha-enhancing neuronal 
tolerance to hypoxia [16–19]. Based on these positive 
findings of HBO2 in animal models, we hypothesized 
that objective measures of clinical brain function and 
recovery would demonstrate improvements. To test this 
hypothesis, we identified the central visual pathways as 
an objective and readily accessible indicator of brain 
health. Eye tracking, which measures the integrity of 
these pathways, has been demonstrated as a user-friendly, 
low-cost, noninvasive marker of individuals with mTBI 
[20–24].
Common assessments of eye tracking include the 
measurement of saccades, smooth pursuit eye movement 
(SPEM), and fixation [23–24]. Saccades, the simultane-
ous movements of both eyes in the same direction allow-
ing for fixation of the image on the fovea, are likely to be 
affected by even mild brain injuries because they involve 
the concerted interactions of multiple and diverse areas 
of the brain [23]. Additionally, the various components of 
saccades are largely free of cognitive influence and not 
interdependent. SPEM has been examined in the trau-
matic brain injury (TBI) population and, although 
believed to be a potential component of the difficult to 
identify and diagnose visual complaints seen with mTBI, 
research has produced equivocal results [24]. Data 
involving fixation, defined as maintaining a foveal 
image, in individuals with TBI have not been well stud-
ied, in part due to technical difficulties in measurement; 
however, advances in both technology and data process-
ing have overcome this.
Investigation of these movement parameters demon-
strated differences between SPEM and saccades in indi-
viduals with PPCS and injury-free controls [20]. These 
differences were noted in horizontal and vertical stepwise 
target displacement task responses between individuals 
with symptomatic mTBI and controls. Subjects with 
symptomatic mTBI had smaller predicted peak veloci-
ties, longer durations, larger position errors, and smaller 
saccadic amplitudes. These symptomatic subjects also 
had amplitudes that were significantly larger for the hori-
zontal smooth pursuit task, were more likely to respond 
with smaller primary saccades to step changes in target 
position, less accurately tracked the stepwise moving 
targets, and had lower pursuit gain than controls [20].
No between-group differences were noted for fixation 
measures.
For this investigation of the effects of HBO2 on 
mTBI-related symptoms, we hypothesized that there 
would be significant differences in postcompression 
SPEM and saccadic eye movements between the sham 
and intervention groups.
METHODS
This study was a sham-controlled, blinded, randomized,
three-arm trial of HBO2 exposure on combat-related, 
symptomatic mTBI that was begun in 2009 at the Naval 
Medicine Operational Training Center (NMOTC) at 
Naval Air Station Pensacola. Other outcome measures 
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from this trial have been reported [11–12]. This study 
received appropriate governmental and institutional 
review board approvals. Sixty-one Active Duty military 
SMs with PPCS were recruited from U.S. military bases. 
Inclusion criteria included confirmed diagnosis of mTBI 
by a TBI specialist, postconcussive symptoms for at least 
3 mo, injury occurrence within 3 yr, at least 2 mo stable 
psychiatric status, and no change in psychotropic medica-
tions for at least 1 mo. The study physiatrist confirmed a 
diagnosis of TBI based on history, physical examination, 
and a review of all the medical records of the subjects, 
including any available battlefield information, from the 
time of the traumatic event to the present. Exclusion cri-
teria included any contraindication to hyperbaric expo-
sure, previous exposure to HBO2, or inability to undergo 
testing (e.g., superimposed ophthalmic conditions such as 
ocular injury and strabismus). All subjects were ques-
tioned as to whether they had any double vision, blurred 
vision, or floaters. Demographics; clinical information; 
and physical, cognitive, and measures of behavioral func-
tioning were obtained.
After baseline testing, all subjects were relocated to 
NMOTC for 2 mo to undergo the hyperbaric chamber 
exposures. The hyperbaric chamber exposures, which 
approximate the community standard of care and meet all 
safety guidelines [8–9], have been described in prior pub-
lications from this research team [10–12].
Statistical Analyses
This article presents an analysis of the effects of the 
hyperbaric chamber exposures on eye tracking character-
istics of the control and treatment group members by 
comparing baseline (time 1) measures to immediate post-
compression (time 2), and 3 mo postcompression (time 3) 
results. Immediate postcompression outcome measure-
ments were obtained within the first week following last 
exposure. Statistical measures of eye tracking were used 
to test for changes within and between subject groups at 
times 1, 2, and 3. Previous research has demonstrated the 
utility of these measures in distinguishing between mTBI 
and normal controls [20].
We analyzed multiple measures (see Figure) using a 
mixed-model analysis of variance (ANOVA), with time 
(times 1, 2, and 3) as the within-subjects factor and oxy-
gen-level (groups A, B, and C) as the between-subjects 
factor. The studentized residuals were analyzed for outli-
ers and normality. 
Figure.
Measures for comparing saccadic and smooth pursuit data.
If there was only one outlier, the analy-
sis was done with and without it. In the cases of multiple 
outliers or a large deviation from the assumption of nor-
mality, we used nonparametric methods (Kruskal-Wallis 
for between-group analysis and Friedman two-way 
ANOVA by ranks for within-group). Levene’s test was 
used to check homogeneity of variances and Box test was 
used to check the assumptions of covariances. Sphericity 
assumptions were also verified and, when violated, were 
corrected using the Greenhouse-Geisser correction.
When the interaction term was significant, the 
assumption of homogeneity of covariances was not met. 
In these cases, we used nonparametric tests and per-
formed separate repeated-measures ANOVAs for each 
oxygen-level group, as well as separate one-way ANO-
VAs between oxygen-level groups at each time point.
Eye Tracking Procedures
The techniques used to obtain the pre- and posthyper-
baric chamber exposure saccadic movement and SPEM 
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have been described in prior publications from this 
research team [20].
RESULTS
One-hundred twenty-eight subjects met the initial 
study eligibility and consented for evaluation. Of the 128 
candidates, 61 met the full study criteria and were randomly
assigned into one of the three groups. Primary reasons for 
exclusion were active medication changes, schedule con-
flicts, and the inability to confirm the diagnosis of mTBI. 
One of the 61 study participants was unavailable for the 
immediate postintervention assessment. Less than 1 per-
cent of all scheduled chamber sessions were postponed 
because of medical complaints and all were rescheduled 
per the protocol. All study subjects were male and had 
sustained at least one mTBI, with the most recent TBI 
occurring a mean of 8.5 mo (standard deviation [SD] = 
6.58 mo, range = 3–39 mo) prior to the baseline assess-
ments. The etiologies of mTBI included improvised 
explosive device blast (85.3%), uncategorized blasts 
(10.0%), rocket propelled grenades (3.0%), and mortar 
attacks (1.7%). Self-reported additional concussions 
(mean = 2.1, SD = 0.95, range = 1–4) prior to the most 
recent blast injury were reported by just over 25 percent 
of the subjects. Of the 60 subjects who completed all of 
the pre- and postcompression procedures, 21 were in the 
sham-control group, 18 were in the 1.5 atmospheres abso-
lute (ATA) equivalent group, and 21 were in the 2.0 ATA
equivalent group. There was no precompression between 
group differences on these variables, as previously 
reported [11–12].
The 60-subject final sample had a mean age of 23.2 yr
(SD = 2.95). Forty-seven (78.3%) were Caucasian, 10 
(16.7 %) were Hispanic, 2 (3.3%) were African Ameri-
can, and 1 (1.7%) was Native American. Of the 60 sub-
jects, 19 were married, 38 were single, and 3 were 
divorced. One-way ANOVA and chi-square analysis 
revealed no between-group differences on demographics. 
There were no clinician-recommended or self-reported 
alterations of psychotropic medications by any subjects 
during the study period.
The symptoms of the research cohort were character-
ized using the Rivermead Post-Concussion Questionnaire 
(RPQ) [25], and these results, which demonstrated no 
between-group differences before or after hyperbaric 
chamber compressions, have been previously reported 
[11]. Specific to this analysis, no subjects reported any 
active difficulty with vision on the three vision-related 
RPQ items—blurred vision, light sensitivity, and double 
vision.
To determine if a treatment effect existed, analyses 
were conducted for the eye tracking variables that had 
been identified as abnormal in prior research [20]. These 
variables were compared for between- and within-group 
differences over the three time periods. At pretreatment, 
there were no significant differences between groups for 
eye movement variables, verifying the efficacy of random-
ization. At immediate and 3 mo postcompression, both
between- and within-group differences were examined.
Saccades
Saccadic data from each group were compared from 
the horizontal and vertical target displacement tasks. 
Data from horizontal and vertical direction eye move-
ments were analyzed for the horizontal and vertical target 
displacement tasks, respectively. For each subject, dura-
tion, peak velocity, saccadic amplitude, and peak acceler-
ation for all saccades were fit to models for both 
horizontal and vertical displacement tasks using the non-
linear curve fitting toolbox in MATLAB (MathWorks; 
Natick, Massachusetts). For peak velocity and accelera-
tion of saccades, exponential models were used, while for 
saccadic duration a power function model was used [26]. 
After curves were fit for each subject, the predicted dura-
tion, peak velocity, and peak acceleration from the mod-
els for both the 1° and 5° saccades were compared 
between and within groups. Other measures of saccadic 
accuracy known to differ between mTBI and normal con-
trols were also compared (Figure) [20]. Measures ana-
lyzed were mean (normalized and non-normalized) of the 
absolute value and SD of the primary and final position 
errors.
Horizontal Tracking
All of the fit data (peak velocity at amplitudes 1 and 
5, peak acceleration at amplitudes 1 and 5, and duration 
at amplitudes 1 and 5), the mean of the normalized pri-
mary position error, and the number of primary saccades 
for the horizontal tracking tasks met the assumptions 
needed for repeated measures ANOVA. For all measures, 
there was no statistically significant interaction (α = 0.05 
level) between the oxygen-condition and time. The main 
effect of oxygen-level showed no statistically significant 
differences between groups, and there were no significant 
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within-group differences over time. When a potential sta-
tistical trend was identified (the p-value was between 0.05
and 0.10 for the interaction term), we performed separate 
repeated measures ANOVAs for each oxygen-condition 
and found no significant differences. p-Values and partial 
eta-squared values are reported for each of the variables 
that met the assumptions for the mixed model ANOVA in 
the Table.
The mean of the normalized final position error, the 
mean of the non-normalized primary position error, and 
the SD of the normalized position error did not meet 
assumptions and so univariate nonparametric tests were 
performed. No significant differences between or within 
groups were found.
Vertical Tracking
All of the data for the vertical tracking tasks met the 
assumptions for parametric tests except for the mean and 
SD of the normalized primary position errors. The data 
for the mean of the normalized final error, predicted 
velocity at 1° and 5°, predicted acceleration at 5°, and 
predicted duration at 1° did not meet the assumption of 
equal covariance, and therefore separate repeated mea-
sures ANOVAs were performed for each oxygen level.
Each variable that met the assumptions was analyzed 
using a mixed-model ANOVA, with time (1, 2, and 3) as 
the within-subjects factor and oxygen level (groups A, B, 
and C) as the between-subjects factor. No significant 
interactions between time and oxygen level were found. 
The main effect of oxygen condition showed no statisti-
cally significant differences between groups, and there 
were no significant within-group differences over time.
Of those variables for whom separate repeated mea-
sures ANOVAs for each group were calculated, no signif-
icant between-group differences on the factor of oxygen 
level were found. Analyses of these measures within 
groups found a statistically significant effect (or trend)
of time for two conditions: predicted velocity (51.25, 
53.23, 49.30 °/s) and acceleration (2,982.98, 3,109.20, 
2,835.02 °/s2) at both 1° and predicted velocity (209.21, 
216.37, 203.19 °/s) and acceleration (11,294.69, 
11,792.24, 10,934.80 °/s2) at 5° amplitudes for group B. 
The difference was only statistically significant between 
times 2 and 3 and reflected a slowing (or worsening) in 
predicted values between times 2 and 3. The clinical rele-
vance of slowing in these two parameters is unclear. No 
other significant differences were found.
When nonparametric analyses were utilized, no sig-
nificant between- or within-group results were found. p-
Values and partial eta-squared values are reported for 
each of the variables that met the assumptions for the 
mixed-model ANOVA in the Table.
Smooth Pursuit
Data for the horizontal and vertical smooth pursuit 
eye movement tasks were analyzed. The minimum gain 
and mean absolute normalized saccadic amplitude for 
both pursuit tasks were analyzed. Only data for the mini-
mum gain from the horizontal smooth pursuit task met 
the assumptions for parametric tests. No significant inter-
action was found between the oxygen-condition factor 
and time (p = 0.36, partial η2 = 0.047). The main effect of 
oxygen condition also showed no statistically significant 
Table.
Mixed-model analysis of variance results: tracking variables.
Tracking
Interaction, Oxygen Level 
and Time
(Between-Subjects) Main 
Effect, Oxygen Level
(Within-Subjects) Main 
Effect, Time
p-Value Partial Eta2 p-Value Partial Eta2 p-Value Partial Eta2
Vertical
Mean of Non-Normalized Primary Position 
Error
0.44 0.051 0.53 0.037 0.24 0.042
Number of Primary Saccades 0.59 0.036 0.84 0.011 0.19 0.048
Horizontal
Mean of Normalized Primary Position Error 0.68 0.028 0.92 0.004 0.66 0.010
Number of Primary Saccades 0.58 0.035 0.66 0.020 0.35 0.026
Predicted Velocity, 1° Amplitude 0.09 0.103 0.74 0.015 0.89 0.002
Predicted Velocity, 5° Amplitude 0.07 0.109 0.81 0.011 0.96 0.000
Predicted Acceleration, 1° Amplitude 0.14 0.088 0.52 0.032 0.90 0.000
Predicted Acceleration 5° Amplitude 0.14 0.087 0.68 0.019 0.99 0.000
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differences between groups (p = 0.10; η2 = 0.097), and 
there were no significant within-group differences over 
time (p = 0.85, η2 = 0.004). Nonparametric univariate 
tests (within- and between-group) were performed on the 
other three variables with no significant within- or 
between-group differences found.
DISCUSSION
This investigation presents injury-related eye track-
ing characteristics from a subanalysis of a DoD-VA col-
laborative trial studying the effects of HBO2 on PPCS. 
This represents the first examination utilizing objective 
eye tracking measurements to assess the potential effect 
of HBO2. In this study, there were no clinically signifi-
cant between-group differences on any of the eye track-
ing variables following hyperbaric chamber 
compressions. While there were within-group differences 
on two of the saccade parameters for one of the oxygen-
condition groups, there were no clinical improvements 
seen in any of the HBO2 conditions. Interestingly, the 
changes seen between times 2 and 3 in this group B 
reflected saccadic slowing rather than improvements in 
eye functioning. The implications of this change are unclear 
but certainly cannot be interpreted as beneficial. There 
were no other statistically significant differences identi-
fied over the array of multiple eye movements studied.
The overall findings of this study were similar to 
findings utilizing other outcome measures in this study 
sample [11–12] and the initial DoD-VA study [10]. The 
lack of differences among the three experimental condi-
tions on these objective eye tracking measures suggests 
the HBO2 exerted no treatment effects on the parameters 
studied. These findings are noteworthy because this study 
specifically utilized the typical treatment pressures advo-
cated by hyperbaric clinicians [13,27–29].
Examinations of oculomotor abnormalities and 
reports of visual dysfunction after mTBI, most com-
monly using the saccadic eye movements and the RPQ as 
outcome measures, have demonstrated that they are most 
likely seen in the first week after injury, maximally 
recover in the initial 3 mo postinjury period and have 
continued recovery for the next 3 mo [21,30–31]. Heitger 
et al., in 2009, reported on 36 civilians who were within 
6 mo of mTBI, and the mean RPQ score for light sensi-
tivity was 1.42, 0.2 for double vision, and 0.78 for 
blurred vision, all of which indicated that none of these 
symptoms were more of a problem than prior to the 
injury [31]. These findings are consistent with our find-
ings of no meaningful visual complaints on the RPQ.
CONCLUSIONS
This study has a number of inherent limitations, as 
previously described [11–12]. The small sample size lim-
its the study’s power. Generalizability may be limited by 
sex. Additionally, the high follow-up rate seen secondary 
to the paid travel and Active Duty status (i.e., they 
received additional duty orders to be on the base) may be 
atypical of nonmilitary populations. A number of factors 
common to most of the study participants may have an as 
yet undetermined effect on eye movements, including 
general combat exposure with associated posttraumatic 
stress, depression, anxiety, substance abuse, and pain, 
which all have been associated with deployment [3–4]. 
Future studies examining the effect of these comorbidi-
ties on eye tracking may be of interest. Better understand-
ing of the influence of deployment and other possible 
variables seen with the subjects, such as time postinjury, 
severity of injury, repeated injury, and medication usage 
and adjustments, may allow for a greater refinement of 
treatment protocols. Diagnosing mTBI relies on partici-
pant self-report, which is sensitive to subjective patient 
interpretation, memory, social desirability, and other 
issues such as personality factors and willingness to 
reveal problems; thus, subjects who report mTBI from 
combat exposure may have characteristics that are not 
typical of all individuals.
This well-controlled study of HBO2 use in symptom-
atic subjects with chronic mTBI demonstrated no signifi-
cant eye movement improvements at either 1.5 or 2.0 ATA
equivalent over sham-control. Importantly, this investiga-
tion incorporated many features lacking in prior studies 
of HBO2 use, including randomization, blinding, objec-
Predicted Duration, 1° Amplitude 0.69 0.026 0.82 0.010 0.40 0.022
Predicted Duration, 5° Amplitude 0.24 0.066 0.85 0.008 0.29 0.031
Table.
Mixed-model analysis of variance results: tracking variables.
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tive outcome measure, and control groups. This investi-
gation does not support a therapeutic role for HBO2 for 
patients with persistent symptoms after mTBI. This 
investigation utilized computerized eye tracking to exam-
ine the possible effects of hyperbaric exposures on indi-
viduals with mTBI with PPCS. There were no clinically 
meaningful improvements associated with the exposure 
to the HBO2.
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